Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Kidney Neoplasms × Selenomethionine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Kidney Neoplasms 1

Interventions

aldesleukin 24 Interferon-alpha 21 Sunitinib 20 Everolimus 16 Sorafenib 15 Cyclophosphamide 15 Gemcitabine 11 Bevacizumab 11 Nivolumab 10 Filgrastim 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Interleukin-2 8 Gene Expression Profiling 8 Axitinib 8 temsirolimus 7 pembrolizumab 7 Doxorubicin 7 Radiosurgery 6 Ipilimumab 6 sargramostim 5 Radiotherapy 5 Polymerase Chain Reaction 5 Ifosfamide 5 Fluorouracil 5 Carboplatin 5 Capecitabine 5 Bortezomib 5 Erlotinib Hydrochloride 4 tanespimycin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02535533 2025-05-20

SLM + Axitinib for Clear Cell RCC

University of Iowa

Phase 1 Completed

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡